Ashley I. Bush
Physiology · 2000–2021
A researcher in the Science corpus: 14 papers; trusts 1 researcher and is trusted by 23 researchers here, as inferred from the citation graph.
Subfields
- Physiology — 31 citations into it; #64 of 2,276 by trust here, #287 by citations
Whom Ashley I. Bush trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Ashley I. Bush overall
- Christos T. Chasapis
- K. Barnham
- Kasper P. Kepp
- K. Jomová
- Ariadni C. Loutsidou
- Claudio Soto
- M. Duchen
- Xueping Chen
- M. Valko
- C. Spiliopoulou
Papers from Ashley I. Bush's perspective
Ordered by how strongly the researchers Ashley I. Bush trusts endorse each paper. Same corpus, a different order for every researcher.
- Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. (Neuron)
- Ferrostatins Inhibit Oxidative Lipid Damage and Cell Death in Diverse Disease Models (Journal of the American Chemical Society)
- Glutaminolysis and Transferrin Regulate Ferroptosis (Molecules and Cells)
- Voluntary Exercise Decreases Amyloid Load in a Transgenic Model of Alzheimer's Disease (Journal of Neuroscience)
- Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. (Archives of Neurology)
- Global Survey of Cell Death Mechanisms Reveals Metabolic Regulation of Ferroptosis (Nature Chemical Biology)
- Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis (eLife)
- Ferroptosis: Death by Lipid Peroxidation. (Trends in Cell Biology)
- Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. (Chemistry and Biology)
- Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy (Nature)
Their papers
- Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. (2017) — 6,633 citations
- Metals and neuroscience. (2000) — 697 citations
- Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. (2008) — 658 citations
- Connecting copper and cancer: from transition metal signalling to metalloplasia (2021) — 1,073 citations
- An iron-export ferroxidase activity of β-amyloid protein precursor is inhibited by zinc in Alzheimer’s Disease (2010) — 660 citations
- The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease (2009) — 979 citations
- Zinc in the physiology and pathology of the CNS (2009) — 739 citations
- Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial. (2008) — 655 citations
- Metals in Alzheimer's and Parkinson's diseases. (2008) — 657 citations
- The neurobiology of zinc in health and disease (2005) — 1,773 citations
- Neurodegenerative diseases and oxidative stress (2004) — 3,753 citations
- The metallobiology of Alzheimer's disease. (2003) — 1,181 citations
- Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. (2003) — 983 citations
- Alzheimer's Disease Amyloid-β Binds Copper and Zinc to Generate an Allosterically Ordered Membrane-penetrating Structure Containing Superoxide Dismutase-like Subunits* (2001) — 600 citations